AMAG snaps up rights to new med Intrarosa to compete with Pfizer’s Premarin® vaginal cream

Tracy Staton reporting for FiercePharma.com writes as follows. AMAG Pharmaceuticals has big ambitions for its women’s health business, so it’s snapped up the rights to a new med, Intrarosa, to beef up that portfolio. The company plans to tout Intrarosa’s safety profile to set it apart from established estrogen-based treatments such as Pfizer’s Premarin cream and… Continue reading AMAG snaps up rights to new med Intrarosa to compete with Pfizer’s Premarin® vaginal cream

Premarin Horses: How many does it take to make a billion dollars? Part 3

Newest Member of the Premarin Family ― Duavee How will this new drug impact profits and inevitably the PMU mares and their foals? DUAVEE®, the Premarin® ― bazedoxifene combination therapy for the treatment of menopausal symptoms and prevention of postmenopausal osteoporosis in women who have not undergone hysterectomy was FDA-approved in October 2013 amid speculation… Continue reading Premarin Horses: How many does it take to make a billion dollars? Part 3

Pfizer to cut jobs at Manitoba PMU plant

Pharma giant says decision won't affect its PMU ranchers Alberta Farm Express reports: Drugmaker Pfizer's restructuring of its estrogen extraction plant at Brandon, Man[itoba] calls for about 40 per cent fewer employees by the end of next year. The company processes conjugated estrogen from pregnant mares' urine (PMU) at Brandon to make the hormone replacement… Continue reading Pfizer to cut jobs at Manitoba PMU plant

Wyeth wins, horses lose, in the Premarin® drug sales sweepstakes

Written by JANE ALLIN Research Analyst | Int'l Fund for Horses Since the introduction of Premarin in 1942, much controversy has followed the lucrative market monopoly of the world’s first conjugated equine estrogen therapy for the treatment of postmenopausal women. Historically, the number of PMU farms, sequestered mares and by-product foals steadily rose until the… Continue reading Wyeth wins, horses lose, in the Premarin® drug sales sweepstakes